INTRANASAL INHALATIONS OF BIOACTIVE FACTORS PRODUCED BY M2 MACROPHAGES IN THE TREATMENT OF PATIENTS WITH ORGANIC BRAIN SYNDROME
The aim of present study was to evaluate safety and clinical efficacy of inhalatory immunotherapy based on intranasal delivery of bioactive factors produced by M2 macrophages applied for treatment of patients with organic brain syndrome (OBS).Materials and methods. The study under the NCT02957123 pr...
Guardado en:
Autores principales: | A. A. Ostanin, M. N. Davydova, N. M. Starostina, L. V. Sakhno, E. Ya. Shevela, E. R. Chernykh |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
SPb RAACI
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/31c6d3581cc745bdb74b5ca50c7880a7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Therapeutic effect of soluble factors of M2 phenotype macrophages in children with language impairments
por: E. Ya. Shevela, et al.
Publicado: (2021) -
M2-LIKE MACROPHAGES ARE POTENTIAL CANDIDATES FOR BRAIN STROKE OUTCOMES' TREATMENT
por: S. A. Morozov, et al.
Publicado: (2012) -
Production of factors involved into fibrosis regulation by various types of human macrophages
por: A. A. Maksimova, et al.
Publicado: (2020) -
The Optimization Design Of Lactoferrin Loaded HupA Nanoemulsion For Targeted Drug Transport Via Intranasal Route
por: Jiang Y, et al.
Publicado: (2019) -
Effects of intranasal Imunofan administration upon phagocytic activity in treatment of exudative otitis media in children
por: E. N. Kologrivova, et al.
Publicado: (2020)